Skip to main content

Table 1 Comparison of the basic information of the training and validation sets

From: Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer

Clinical characters

Level

Training set (n = 98)

Validation set (n = 41)

p value

Age (years, mean [SD])

–

54.28 (10.57)

54.61 (12.25)

0.872

Menopause (%)

False

31 (32.3)

13 (32.5)

1

True

65 (67.7)

27 (67.5)

T stage (%)

1

48 (49.0)

14 (34.1)

0.206

2

46 (46.9)

26 (63.4)

3

4 (4.1)

1 (2.4)

N stage (%)

0

56 (58.3)

27 (65.9)

0.226

1

23 (24.0)

12 (29.3)

2

12 (12.5)

2 (4.9)

3

5 (5.2)

0 (0.0)

Stromal TILs (%)

High

56 (57.1)

23 (56.1)

1

Low

42 (42.9)

18 (43.9)

Ki-67 [mean (SD)]

–

56.99 (21.90)

64.27 (26.14)

0.094

Molecular subtype (%)

BLIS

29 (29.6)

13 (31.7)

0.709

IM

21 (21.4)

9 (22.0)

LAR

17 (17.3)

8 (19.5)

MES

16 (16.3)

3 (7.3)

Unknown

15 (15.3)

8 (19.5)

  1. SD standard deviation, BLIS basal-like immune-suppressed, IM immunomodulatory, LAR luminal androgen receptor, MES mesenchymal-like